Treatment of Long CoronaVirus Disease (COVID) (TLC) Feasibility Trial
Status:
Recruiting
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the feasibility and acceptability of methods
and procedures to be employed in a larger scale decentralized platform adaptive randomized
clinical trial in patients with a history of a Severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) Polymerase Chain Reaction (PCR) positive test and/or medical records from a
healthcare provider that coincides with the diagnosis of long-COVID.